Histoplasmosis of the Upper Extremities: Clinical Case, Treatment Algorithm, and Systematic Review

Hand ◽  
2020 ◽  
pp. 155894472091121
Author(s):  
Maria T. Huayllani ◽  
David J. Restrepo ◽  
Daniel Boczar ◽  
Andrea Sisti ◽  
Brian D. Rinker ◽  
...  

Background: Histoplasmosis of the upper extremities is extremely rare, and there is no consensus in its management. The aim of this study was to present a case report and literature review of histoplasmosis in the upper extremities to provide the best treatment recommendation and to increase awareness of this disease. Methods: A systematic review of the literature was performed in PubMed, MEDLINE, and EMBASE databases with the search terms “(Tenosynovitis AND histoplasmosis)” OR “(Upper limbs AND histoplasmosis)” OR “(Upper extremities AND histoplasmosis)” OR “((finger OR arm OR hand OR forearm OR wrist) AND histoplasmosis).” Manuscripts were included in the study if they described diagnosis of histoplasmosis in the bone, joint, synovia, or tendons of the upper extremities. Results: In all, 14 manuscripts and 15 cases of histoplasmosis of the upper extremities from 1992 to 2015 met the inclusion criteria. Eight (53.3%) patients were diagnosed with tenosynovitis, 5 (33.3%) with osteomyelitis, 1 (6.7%) with carpal tunnel syndrome, and 1 (6.7%) with joint wrist abscess. Immunosuppression, travel history, previous diagnosis with histoplasmosis, and persistent symptoms may suggest infectious causes. Surgery and medical treatment together are recommended to optimize outcomes compared with single treatment alone. Conclusions: Histoplasmosis of the upper extremities may have various clinical presentations, including tenosynovitis, osteomyelitis, carpal tunnel syndrome, and joint wrist abscess. The type of surgical approach may depend on the etiology of disease. Increased awareness and knowledge of the clinical signs, symptoms, and effective treatment modalities will help decrease possible complications, such as tendon rupture and functional impairment of the upper extremities.

Author(s):  
Ji Eun Son ◽  
Tae Woon Jang ◽  
Yoon Kou Kim ◽  
Young Seoub Hong ◽  
Kap Yeol Jung ◽  
...  

2021 ◽  
pp. 175319342110017
Author(s):  
Saskia F. de Roo ◽  
Philippe N. Sprangers ◽  
Erik T. Walbeehm ◽  
Brigitte van der Heijden

We performed a systematic review on the success of different surgical techniques for the management of recurrent and persistent carpal tunnel syndrome. Twenty studies met the inclusion criteria and were grouped by the type of revision carpal tunnel release, which were simple open release, open release with flap coverage or open release with implant coverage. Meta-analysis showed no difference, and pooled success proportions were 0.89, 0.89 and 0.85 for simple open carpal tunnel release, additional flap coverage and implant groups, respectively. No added value for coverage of the nerve was seen. Our review indicates that simple carpal tunnel release without additional coverage of the median nerve seems preferable as it is less invasive and without additional donor site morbidity. We found that the included studies were of low quality with moderate risk of bias and did not differentiate between persistent and recurrent carpal tunnel syndrome.


Author(s):  
Ahmed M. Ahmed ◽  
Osama G. Hassan ◽  
Ahmed A. Khalifa

Abstract Background Carpal tunnel syndrome (CTS) is a common upper limb entrapment neuropathy; severe cases are treated surgically and mild to moderate can be managed conservatively. The purpose of this systematic review and meta-analysis was to define the efficacy of gabapentin as an adjuvant to splinting in the treatment of mild to moderate CTS. Methods A systematic search through 13 databases, randomized clinical trials (RCTs) reporting the use of gabapentin with splinting in CTS were included and analyzed. Results Three RCTs including 170 patients were eligible. There was no significant difference between gabapentin plus splinting and splinting alone in 5 measured parameters: (1) Symptom Severity Scale (SSS) [MD (95% CI) = − 0.76 (− 2.46–0.93), p = 0.378], (2) Functional Status Scale (FSS) [MD (95% CI) = − 0.23 (− 1.40–0.94), p = 0.701], (3) visual analogue scale (VAS) to assess pain [MD (95% CI) = − 0.6 (− 1.47–0.27), p = 0.174], (4) Grip strength [MD (95% CI) = − 0.11 (− 0.70–0.48), p = 0.718], and (5) pinch strength [MD (95% CI) = 0.72 (− 0.10–1.54), p = 0.083]. Conclusion This review provides low-quality evidence that gabapentin plus nocturnal splinting is not superior to splinting alone. More high-quality trials are needed to determine the role of this drug as an adjuvant in the management of CTS.


2007 ◽  
Vol 21 (4) ◽  
pp. 299-314 ◽  
Author(s):  
D.B. Piazzini ◽  
I. Aprile ◽  
P.E. Ferrara ◽  
C. Bertolini ◽  
P. Tonali ◽  
...  

2004 ◽  
Vol 17 (2) ◽  
pp. 210-228 ◽  
Author(s):  
Monique Muller ◽  
Deborah Tsui ◽  
Ronda Schnurr ◽  
Lori Biddulph-Deisroth ◽  
Julie Hard ◽  
...  

2021 ◽  
Vol 16 (2) ◽  
pp. 9-19
Author(s):  
Sun-Young Park ◽  
Sang-Hyun Lee ◽  
In Heo ◽  
Eui-Hyoung Hwang

2019 ◽  
Vol 45 (11) ◽  
pp. 2855-2865 ◽  
Author(s):  
Chih-Peng Lin ◽  
Ing-Jeng Chen ◽  
Ke-Vin Chang ◽  
Wei-Ting Wu ◽  
Levent Özçakar

2017 ◽  
Vol 30 (1) ◽  
pp. 3-12 ◽  
Author(s):  
Richard Ellis ◽  
Rebecca Blyth ◽  
Nick Arnold ◽  
Warren Miner-Williams

Sign in / Sign up

Export Citation Format

Share Document